BBIOCongressional Stock Trades
BridgeBio Pharma, Inc. Common Stock
Pharmaceutical Preparations
Congressional stock trades in BridgeBio Pharma, Inc. Common Stock (BBIO) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
2
Politicians Trading
1
Last Traded
Sep 22, 2025
Price History
About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.